Table 2.
The number of participants considered for the imaging-clinical/cognition correlation analyses across the five disease categories.
| Phenotypes | CN | SMC | EMCI | LMCI | AD |
|---|---|---|---|---|---|
| Clinical | |||||
| ADAS13 (N=254) | 57 | 31 | 72 | 25 | 69 |
| MMSE (N=255) | 57 | 31 | 73 | 25 | 69 |
| MOCA (N=248) | 57 | 31 | 71 | 25 | 64 |
| RAVLT_immediate (N=251) | 56 | 31 | 73 | 25 | 66 |
| RAVLT_learning (N=251) | 56 | 31 | 73 | 25 | 66 |
| RAVLT_forgetting (N=250) | 56 | 31 | 73 | 25 | 65 |
| FAQ (N=251) | 56 | 31 | 69 | 25 | 70 |
| EcogPtTotal (N=249) | 57 | 31 | 72 | 25 | 64 |
| EcogSPTotal (N=246) | 56 | 30 | 65 | 25 | 70 |
| CDRSB (251) | 56 | 30 | 70 | 25 | 70 |
| AD-pathology related | |||||
| CSF_ABETA (N=50) | 12 | 12 | 6 | 4 | 16 |
| CSF_TAU (N=62) | 14 | 17 | 10 | 5 | 16 |
| CSF_PTAU (N=62) | 14 | 17 | 10 | 5 | 16 |
| [18F]Florbetapir PET (AV45) (N=134) | 36 | 25 | 30 | 12 | 31 |
| FDG_PET (N=44) | 13 | 4 | 10 | 3 | 14 |